一种基于脏器官的读数,用于评估原发性和复发性焦点细分型淋巴结核硬化症的疾病活性

Ashwani Kumar Gupta1, Ekta Minocha2, Kyle M Koss3

  • 1Department of Surgery, University of Arizona College of Medicine, Tucson, Arizona, USA; Bio5 Institute, University of Arizona, Tucson, Arizona, USA; Surgery Service, Southern Arizona Veterans Affairs Health Care System, Tucson, Arizona, USA; Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Kidney international
|February 6, 2025
PubMed
概括

用患者血模型初级焦点细分样硬化症 (pFSGS) 治疗的器官. 这一进展可能有助于预测移植后的pFSGS复发风险.